Humana Inc announces it is expanding the availability of its Total Joint Replacement Episode-Based Model by teaming up with orthopedic specialty groups in seven additional states.
These states, where the value-based care bundled payment model for Humana Medicare Advantage members undergoing total hip or knee joint replacement procedures are now being accepted, are Alabama, Florida, Georgia, Illinois, Louisiana, Mississippi, and Texas.
Humana’s newest provider agreements are with Alabama Orthopaedic Clinic in Alabama; Florida Medical Clinic in Florida; OrthoAtlanta Orthopedic and Sports Medicine Specialists, Peachtree Orthopedics, and Resurgens Orthopaedics in Georgia; Illinois Bone & Joint Institute and OrthoIllinois in Illinois; Ascendant Orthopedic Alliance in Indiana; Bone & Joint Clinic of Baton Rouge in Louisiana; Bienville Orthopaedic Specialists and Mississippi Sports Medicine and Orthopaedic Center in Mississippi; Center for Sports Medicine & Orthopaedics in Tennessee; TSAOG Orthopaedics in Texas; and Atlantic Orthopaedic Specialists, OrthoVirginia, and Riverside Medical Group in Virginia, according to a media release.
“We’re excited to accelerate this innovative value-based care model into additional markets, significantly growing the reach of a program specifically tailored for orthopedics,” says Caraline Coats, vice president of Humana’s Provider Development Center of Excellence, in the release.
“Humana is dedicated to building relationships with physicians and providing the support they need as we work together to create a more seamless, patient-centered experience and help members achieve their best health.”
The orthopedic specialty care model is designed to improve quality, outcomes, and cost across a member’s entire joint replacement episode of care, and it financially incentivizes orthopedic surgeons for better outcomes.
Humana provides participating orthopedic practices with robust data and analytics to enhance patient care—from diagnosis to recovery—and the program is designed to deliver a more coordinated care experience for the patient, with reductions in readmission and complication rates, the release continues.
[Source(s): Humana, Business Wire]
